Ready, it's good to disagree on this board. I like to hear other people's opinion on all issues, including why NWBO fell a few patients short of completing enrollment. In fact, I would like to hear your opinion. it's easy to criticize; not so easy to run the show as Linda and company do. My theory may very well be completely wrong, but at least I've put a theory out there. I can come up with others.... Maybe the safety board did its effecacy evaluation and it was so good, they showed it to the FDA and they're busy examining the data, and asked them to halt screening until they finished. Maybe they applied for Fast Track or maybe the Germans and European regulatory boards are looking at data. Maybe the FDA is spending five months trying to decide whether to close them down.
Hopefully we'll know soon, but frankly it's a good idea when you're invested in a company to try to see all the possibilities before the final hand is shown. So, please show us your theory.
News 
Market Data 
Discover 
